Role of IFIT4 in Lupus and Monocyte Differentiation
Author Information
Author(s): Huang Xiangyang, Shen Nan, Bao Chunde, Gu Yueying, Wu Li, Chen Shunle
Primary Institution: Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine
Hypothesis
Does IFIT4 play a role in monocyte differentiation and correlate with clinical manifestations of systemic lupus erythematosus (SLE)?
Conclusion
IFIT4 may contribute to the pathogenesis of SLE by promoting monocyte differentiation into dendritic cells.
Supporting Evidence
- IFIT4 mRNA and protein levels were significantly higher in SLE patients compared to healthy controls.
- Higher IFIT4 expression correlated with the presence of autoantibodies in SLE patients.
- IFIT4-primed dendritic cell-like cells exhibited enhanced ability to stimulate T-cell proliferation.
Takeaway
IFIT4 is a protein that helps certain blood cells change into immune cells, which might be important in a disease called lupus.
Methodology
The study used plasmid transfection, flow cytometry, ELISA, quantitative RT-PCR, and Western blotting to analyze IFIT4's role.
Potential Biases
Potential bias due to the study being conducted at a single institution.
Limitations
The study primarily involved a specific ethnic group (Chinese), which may limit generalizability.
Participant Demographics
108 SLE patients (96 female, 12 male) and 46 healthy donors (40 female, 6 male), all of Chinese ethnicity.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website